Holen Sie sich die Stockscreener-App
1.72
2.54%
-0.05
Schlusskurs vom Vortag:
$1.77
Offen:
$1.75
24-Stunden-Volumen:
514.09K
Relative Volume:
0.15
Marktkapitalisierung:
$357.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-283.26M
KGV:
-1.1701
EPS:
-1.47
Netto-Cashflow:
$-273.61M
1W Leistung:
+8.49%
1M Leistung:
+0.88%
6M Leistung:
-55.99%
1J Leistung:
-80.22%
1-Tages-Spanne:
$1.72
$1.82
1-Wochen-Bereich:
$1.61
$1.91
52-Wochen-Spanne:
$1.26
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.725 | 357.79M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
494.76 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
612.15 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
617.17 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.69 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
251.34 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to - Bluefield Daily Telegraph
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Sells 110,538 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Sana Biotechnology Inc (SANA) Stock: A Year of Decreases and Increases - investchronicle.com
Press Release Distribution & PR Platform - ACCESS Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action ... - Bluefield Daily Telegraph
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors - GlobeNewswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Sana stock holds $11 target with Buy rating at H.C. Wainwright - Investing.com India
Citizens JMP upgrades Sana Biotechnology Inc (SANA) stock to a Mkt outperform - knoxdaily.com
Class Action Filed Against Sana Biotechnology, Inc. (SANA)May 20, 2025 Deadline to Join – Contact The Gross Law Firm - TradingView
Taking on analysts’ expectations and winning: Sana Biotechnology Inc (SANA) - Sete News
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - PR Newswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TradingView
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking Recovery – Contact - Bluefield Daily Telegraph
Lost Money on Sana Biotechnology, Inc.(SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - The Malaysian Reserve
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana ... - Bluefield Daily Telegraph
The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - PR Newswire
Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to - Bluefield Daily Telegraph
Investors in Sana Biotechnology, Inc. Should Contact The - GlobeNewswire
Shareholders That Lost Money on Sana Biotechnology, Inc. (SANA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - Eastern Progress
SANA Investors Have the Opportunity to Lead the Sana - GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
KLP Kapitalforvaltning AS Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sana Biotechnology Inc-Aktie (SANA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):